Since 1976 the Syllabus for Pharmaceutical Medicine has been developed by the Royal Colleges of Physicians in the UK for the Diploma in Pharmaceutical Medicine exam, and as the basis for course curricula in postgraduate training in the discipline, and subsequently specialty, of pharmaceutical medicine. Over the years the Syllabus underwent a number of revisions and updates under the auspices of the Colleges, and since 1989 by FPM. In 1985 FPM’s Syllabus for Pharmaceutical Medicine was offered to IFAPP as the basis for the IFAPP Syllabus for Pharmaceutical Medicine, utilised for course curricula and exams in Europe and by IFAPP National Member Associations around the world.
The syllabus for CPM is based on the PharmaTrain 2018 Syllabus. The syllabus is divided into sections covering the below sections. For more information download the full syllabus (pdf).
Section 1 – Discovery of Medicines
Section 2 – Development of Medicines: Planning
Section 3 – Non-Clinical Testing
Section 4 – Pharmaceutical Development
Section 5 – Exploratory Development (Molecule to Proof-of-Concept)
Section 6 – Confirmatory Development: Strategies
Section 7 – Clinical Trials
Section 8 – Ethics and Legal Issues
Section 9 – Data Management and Statistics
Section 10 – Regulatory Affairs
Section 11 – Drug Safety, Pharmacovigilance and Pharmacoepidemiology
Section 12 – Information, Promotion and Education
Section 13 – Economics of Healthcare, Health Econocmincs and Pharmacoeconomics
Please note the following:
FPM led a project on behalf of the PharmaTrain Federation and the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) to update the 2010 PharmaTrain Syllabus. The output, the 2018 PharmaTrain Syllabus came into effect in January 2018. The syllabus is used worldwide by the universities and course providers that design and run courses and exams in pharmaceutical medicine. FPM uses the syllabus to write questions for the CPM exam.